跳至主要内容
临床试验/CTRI/2016/07/007115
CTRI/2016/07/007115已完成4 期

Safety and Efficacy of Axiostat® hemostatic dressing on radial access after percutaneous procedure

Axio Biosolutions Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Age greater than or equal to 18 years.
  • 2. Patient and/or patientâ??s legal representative and/or
  • impartial witness has/have been informed of the nature of
  • the study and agrees to its provision and has provided written
  • informed consent as approved by the Ethics Committee of the
  • investigative site.
  • 3. Iatrogenic Incision
  • 4. Patient who want to undergo radial intervention.
  • 5. All incision size must be less than 5cm.

排除标准

  • 1. Prior diagnosis of disease or medical condition affecting the
  • ability of blood to clot (e.g., hemophilia.).
  • 2. Patients with known sensitivity to chitosan (shellfish)
  • used in this study.
  • 3. Patients who, in the opinion of the Investigator, may not
  • complete the study for any reason, e.g. Patient requiring
  • Immediate suturing.
  • 4. Patient is currently participating in an investigational drug
  • or dressing study that has not yet completed its primary endpoint interferes with procedure and assessments in this
  • 5. Pregnant women.
  • 6. Patients with hemorrhagic shock.
  • 7. Patient having hemoglobin < 9 g/dl.

研究者

发起方
Axio Biosolutions Pvt Ltd

相似试验

To evaluate effect of Axiostat® to stop bleeding in... | 临床试验